A5V4d

Weisse et al., 1987
References
Weisse,M.E., Miller,G., Brien,J.H., Fever response to acetaminophen in viral vs. bacterial infections,
Pediatric Infectious Disease Journal, 6, 1091-1094, 1987
Wells et al., 2001
Wells,L.C., Smith,J.C., Weston,V.C., Collier,J., Rutter,N., The child with a non-blanching rash: how
likely is meningococcal disease?, Archives of Disease in Childhood, 85, 218-222, 2001
Wilson et al., 1991
Wilson,J.T., Brown,R.D., Kearns,G.L., Eichler,V.F., Johnson,V.A., Bertrand,K.M., Lowe,B.A., Singledose,
placebo-controlled comparative study of ibuprofen and acetaminophen antipyresis in children,
Journal of Pediatrics, 119, 803-811, 1991
Woelker et al., 2012
Woelker,J.U., Sinha,M., Christopher,N.C., Powell,K.R., Serum procalcitonin concentration in the
evaluation of febrile infants 2 to 60 days of age, Pediatric Emergency Care, 28, 410-415, 2012
Wong et al., 2001
Wong,A., Sibbald,A., Ferrero,F., Plager,M., Santolaya,M.E., Escobar,A.M., Campos,S., Barragan,S.,
De Leon,Gonzalez M., Kesselring,G.L., Fever Pediatric Study Group, Antipyretic effects of dipyrone
versus ibuprofen versus acetaminophen in children: results of a multinational, randomized, modified
double-blind study, Clinical Pediatrics,Clin.Pediatr., 40, 313-324, 2001
Yamamoto et al., 1987
Yamamoto,L.T., Wigder,H.N., Fligner,D.J., Rauen,M., Dershewitz,R.A., Relationship of bacteremia to
antipyretic therapy in febrile children, Pediatric Emergency Care, 3, 223-227, 1987
Yeboah-Antwi et al., 2008
Yeboah-Antwi,K., ddo-Yobo,E., du-Sarkodie,Y., Carlin,J.B., Plange-Rhule,G., Osei,Akoto A.,
Weber,M.W., Hamer,D.H., Clinico-epidemiological profile and predictors of severe illness in young
infants (0-59 days) in Ghana, Annals of Tropical Paediatrics, 28, 35-43, 2008
Young Infants Clinical Signs Study Group, 2008
Young Infants Clinical Signs Study Group, Clinical signs that predict severe illness in children under
age 2 months: a multicentre study, Lancet, 371, 135-142, 2008
Zarkesh et al., 2011
Zarkesh,M., Hashemian,H., Momtazbakhsh,M., Rostami,T., Assessment of febrile neonates according
to low risk criteria for serious bacterial infection, Iranian Journal of Pediatrics, 21, 436-440, 2011
Zorc et al., 2005
Zorc,J.J., Levine,D.A., Platt,S.L., Dayan,P.S., Macias,C.G., Krief,W., Schor,J., Bank,D., Shaw,K.N.,
Kuppermann,N., Multicenter RSV-SBI Study Group of the Pediatric Emergency Medicine
Collaborative Research Committee of the American Academy of Pediatrics., Clinical and demographic
factors associated with urinary tract infection in young febrile infants, Pediatrics, 116, 644-648, 2005
References [2007]
1. Hay AD. The prevalence of symptoms and consultations in pre-school children in the Avon
Longitudinal Study of Parents and Children (ALSPAC): A prospective cohort study. Family Practice
2005;22(4):367–74.
2. Singhal A, Morley R, Abbott R, et al. Clinical safety of iron-fortified formulas. Pediatrics
2000;105:e38.
3. Saxena S, Majeed A, Jones M. Socio-economic differences inchildhood consultation rates in
general practice in England and Wales: prospective cohort study. British Medical Journal
1999;318:642–6.
271
2013 Update